Chemoinformaics analysis of 2-Oxobutyl acetate
| Molecular Weight | 130.143 | nRot | 3 |
| Heavy Atom Molecular Weight | 120.063 | nRig | 2 |
| Exact Molecular Weight | 130.063 | nRing | 0 |
| Solubility: LogS | -0.423 | nHRing | 0 |
| Solubility: LogP | 0.28 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 19 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 19.0939 |
| nHD | 0 | BPOL | 13.5041 |
| QED | 0.523 |
| Synth | 2.213 |
| Natural Product Likeliness | 0.948 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.012 |
| Pgp-sub | 0.01 |
| HIA | 0.006 |
| CACO-2 | -4.321 |
| MDCK | 0.0000403 |
| BBB | 0.98 |
| PPB | 0.264308 |
| VDSS | 0.554 |
| FU | 0.85126 |
| CYP1A2-inh | 0.066 |
| CYP1A2-sub | 0.122 |
| CYP2c19-inh | 0.028 |
| CYP2c19-sub | 0.336 |
| CYP2c9-inh | 0.004 |
| CYP2c9-sub | 0.153 |
| CYP2d6-inh | 0.015 |
| CYP2d6-sub | 0.273 |
| CYP3a4-inh | 0.009 |
| CYP3a4-sub | 0.248 |
| CL | 6.607 |
| T12 | 0.943 |
| hERG | 0.042 |
| Ames | 0.912 |
| ROA | 0.02 |
| SkinSen | 0.479 |
| Carcinogencity | 0.165 |
| EI | 0.985 |
| Respiratory | 0.065 |
| NR-Aromatase | 0.004 |
| Antiviral | No |
| Prediction | 0.973242 |